Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review
- Citation:
- Kassem, L., K. S. Shohdy, S. Lasheen, O. Abdel-Rahman, A. Ali, and R. R. Abdel-Malek,
"Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review",
Critical Reviews in Oncology/Hematology, vol. 134, pp. 56-64, 2019.
